NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, June 1st will be given a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Thursday, May 31st. This is an increase from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a stock buyback plan on Wednesday, February 21st 2018, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The medical instruments supplier earned $2.68 billion during the quarter, compared to analysts' expectations of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The company's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 analysts have issued twelve-month price targets for Baxter International's shares. Their predictions range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next year. View Analyst Ratings for Baxter International.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), FRESENIUS SE &/S (FSNUY), Boston Scientific (BSX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Insulet (PODD), Globus Medical (GMED), Penumbra (PEN) and Haemonetics (HAE).

News articles about BAX stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a media sentiment score of 0.06 on Accern's scale. They also assigned headlines about the medical instruments supplier an impact score of 46.75 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Baxter International's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.05%), Veritas Asset Management LLP (1.77%), Northern Trust Corp (1.65%), Wells Fargo & Company MN (1.07%), Old Mutual Global Investors UK Ltd. (0.65%) and Legal & General Group Plc (0.53%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN, Aristotle Capital Management LLC, CI Global Investments Inc., Veritas Asset Management LLP and Northern Trust Corp. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Point72 Asset Management L.P., The Manufacturers Life Insurance Company, Natixis, Old Mutual Global Investors UK Ltd., BNP Paribas Arbitrage SA, Mackay Shields LLC and Eaton Vance Management. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $74.32.

Baxter International has a market capitalization of $39.49 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]